Owners, management and financials
CVR: 26638445
DKK 163,565
Gross profit
Net result: DKK 137,190
Helene Lollike Bull (5-9,99%), Fitzrovia ApS (90-99,99%)
CVR · view owners
Jesper Gjelstrup
Board: Steen Nordstrøm (chair) and 3 members
CVR · view management
Active
Founded 6 June 2002
CVR · view overview
23 employees
CVR · 2018
Director role ended: Jacob Gjelstrup
CVR · 06/08/2024
View the full event history
DIAFARM A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2002. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Jesper Gjelstrup. The board consists of Steen Nordstrøm (chair), Allan Christensen, Jacob Gjelstrup and Jesper Gjelstrup. The company is owned by Helene Lollike Bull and Fitzrovia ApS. The company has 23 employees (2018). In 2025, the company reported a gross profit of DKK 163,565 and a net result of DKK 137,190 compared with DKK 330,620 the year before. Equity in the 2025 report amounted to DKK 3,304,126.
Selskabets formål er at drive virksomhed med salg af fodertilskud og pleje produkter mv. til selskabsdyr (hus og kæledyr) samt produktionsdyr, på det internationale marked
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 164 t. | 137 t. | 3.4 mio. | 3.3 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | 362 t. | 331 t. | 3.7 mio. | 3.2 mio. | - | |
| 202301/01/2023 – 31/12/2023 | 739 t. | 574 t. | 4.7 mio. | 4 mio. | - | |
| 202201/01/2022 – 31/12/2022 | 333 t. | 231 t. | 5.1 mio. | 3.9 mio. | - | |
| 202101/01/2021 – 31/12/2021 | 274 t. | 148 t. | 4.9 mio. | 3.6 mio. | 0 | |
| 202001/01/2020 – 31/12/2020 | 14.1 mio. | 1.2 mio. | 16 mio. | 3.5 mio. | 25 | |
| 201901/01/2019 – 31/12/2019 | 13 mio. | 1.4 mio. | 14.6 mio. | 3.9 mio. | 19 | |
| 201801/01/2018 – 31/12/2018 | 12.6 mio. | 1.2 mio. | 15.3 mio. | 3.5 mio. | 20 | |
| 201701/01/2017 – 31/12/2017 | 11.1 mio. | 1.2 mio. | 15.1 mio. | 3.2 mio. | 19 | |
| 201601/01/2016 – 31/12/2016 | 9.1 mio. | 99 t. | 14 mio. | 2.1 mio. | 18 | |
| 201501/01/2015 – 31/12/2015 | 9.8 mio. | 1.2 mio. | 15 mio. | 2.7 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 9.2 mio. | 1 mio. | 9.8 mio. | 2.2 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 7.9 mio. | 844 t. | 8.7 mio. | 2 mio. | - | |
| 201201/01/2012 – 31/12/2012 | 7.1 mio. | 406 t. | 8.3 mio. | 1.4 mio. | - |
Compared to 86 companies in Fremstilling af parfume, hårshampoo, tandpasta mv.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorThe CVR number of DIAFARM A/S is 26638445.
DIAFARM A/S is owned by Helene Lollike Bull and Fitzrovia ApS.
The management of DIAFARM A/S consists of Jesper Gjelstrup.
The board of DIAFARM A/S consists of Steen Nordstrøm, Allan Christensen and Jacob Gjelstrup, with Steen Nordstrøm as chair.
In 2025, DIAFARM A/S reported a gross profit of DKK 163,565.
DIAFARM A/S had 23 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
DIAFARM A/S has published its annual report for 2025. Gross profit came to DKK 163,565, and the net result was DKK 137,190.
DIAFARM A/S has published its annual report for 2024. Gross profit came to DKK 361,610, and the net result was DKK 330,620.
As of January 20, 2025, Allan Christensen has joined the board of directors of DIAFARM A/S.
As of August 6, 2024, Steen Nordstrøm has joined the board of directors of DIAFARM A/S.
As of August 6, 2024, Jacob Gjelstrup has stepped down as director of DIAFARM A/S.
As of August 5, 2024, Steen Nordstrøm has left the board of directors of DIAFARM A/S.
As of July 9, 2024, Peter Vammen has left the board of directors of DIAFARM A/S.
DIAFARM A/S has published its annual report for 2023. Gross profit came to DKK 739,487, and the net result was DKK 573,795.
As of October 1, 2023, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of DIAFARM A/S.
As of October 1, 2023, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has stepped down as auditor of DIAFARM A/S.
As of April 14, 2023, Fitzrovia ApS is registered as an owner of DIAFARM A/S with an ownership share of 90%.
DIAFARM A/S has published its annual report for 2022. Gross profit came to DKK 332,780, and the net result was DKK 230,683.
DIAFARM A/S has published its annual report for 2021. Gross profit came to DKK 273,730, and the net result was DKK 148,120.
DIAFARM A/S has published its annual report for 2020. Gross profit came to DKK 14,136,228, and the net result was DKK 1,220,088.
As of June 17, 2020, Johannes Gjelstrup has left the board of directors of DIAFARM A/S.
As of June 17, 2020, Helene Lollike Bull is registered as an owner of DIAFARM A/S with an ownership share of 5%.
DIAFARM A/S has published its annual report for 2019. Gross profit came to DKK 12,978,013, and the net result was DKK 1,438,664.
DIAFARM A/S has published its annual report for 2018. Gross profit came to DKK 12,628,495, and the net result was DKK 1,232,742.
As of September 14, 2018, Benny Andersen has stepped down as director of DIAFARM A/S.
DIAFARM A/S has published its annual report for 2017. Gross profit came to DKK 11,081,540, and the net result was DKK 1,185,527.
As of January 1, 2018, Jacob Gjelstrup is registered as director of DIAFARM A/S.
As of January 1, 2018, Benny Andersen is registered as director of DIAFARM A/S.
As of December 31, 2017, Benny Andersen has left the board of directors of DIAFARM A/S.
As of August 1, 2017, Benny Andersen has joined the board of directors of DIAFARM A/S.
DIAFARM A/S has published its annual report for 2016. Gross profit came to DKK 9,083,804, and the net result was DKK 98,999.
DIAFARM A/S has published its annual report for 2015. Gross profit came to DKK 9,751,506, and the net result was DKK 1,243,562.
As of September 1, 2015, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has been appointed auditor of DIAFARM A/S.
As of September 1, 2015, REVISIONSFIRMAET KVIST OG JENSEN A/S has stepped down as auditor of DIAFARM A/S.
DIAFARM A/S has published its annual report for 2014. Gross profit came to DKK 9,176,686, and the net result was DKK 1,012,664.
As of August 1, 2014, Steen Nordstrøm has joined the board of directors of DIAFARM A/S.
DIAFARM A/S has published its annual report for 2013. Gross profit came to DKK 7,865,994, and the net result was DKK 844,306.
As of November 7, 2013, REVISIONSFIRMAET KVIST OG JENSEN A/S has been appointed auditor of DIAFARM A/S.
As of November 7, 2013, JUT NR. 2180 A/S has stepped down as auditor of DIAFARM A/S.
DIAFARM A/S has published its annual report for 2012. Gross profit came to DKK 7,118,443, and the net result was DKK 406,203.
As of June 6, 2012, Johannes Gjelstrup has joined the board of directors of DIAFARM A/S.
As of June 6, 2012, Peter Vammen has joined the board of directors of DIAFARM A/S.
As of May 20, 2010, Jesper Gjelstrup is registered as adm. dir. of DIAFARM A/S.
As of May 20, 2010, Johannes Gjelstrup has stepped down as director of DIAFARM A/S.
As of July 7, 2006, JUT NR. 2180 A/S has been appointed auditor of DIAFARM A/S.
As of July 7, 2006, REVISIONSFIRMAET JENS EBSEN ApS has stepped down as auditor of DIAFARM A/S.
As of September 2, 2002, Jacob Gjelstrup has joined the board of directors of DIAFARM A/S.
As of September 2, 2002, Jesper Gjelstrup has joined the board of directors of DIAFARM A/S.
As of June 6, 2002, REVISIONSFIRMAET JENS EBSEN ApS has been appointed auditor of DIAFARM A/S.
As of June 6, 2002, Johannes Gjelstrup is registered as director of DIAFARM A/S.
DIAFARM A/S was founded on June 6, 2002.
Companies in the same industry and area
CVR 39181274
CVR 41796979
CVR 36393440
CVR 43995022
CVR 44884968
